chr17:39679869:> Detail (hg19)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr17:39,679,869-39,684,560 |
| hg38 | chr17:41,523,617-41,528,308 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
| Score | Disease name | Description | Source | Pubmed | Links |
|---|---|---|---|---|---|
| 0.005 | squamous cell carcinoma | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree,LHGDN | 25453845 | Detail |
| <0.001 | Carcinoma, Transitional Cell | NA | BeFree | Detail | |
| 0.120 | Neoplastic Cell Transformation | NA | CTD_human | Detail | |
| 0.001 | Malignant tumor of cervix | NA | BeFree | Detail | |
| <0.001 | bile duct adenoma | NA | BeFree | Detail | |
| 0.003 | colorectal carcinoma | NA | BeFree | Detail | |
| 0.003 | Colorectal Neoplasms | NA | LHGDN | Detail | |
| <0.001 | Cyst | NA | BeFree | Detail | |
| <0.001 | Hematological Disease | NA | BeFree | Detail | |
| <0.001 | hepatitis B | NA | BeFree | Detail | |
| 0.121 | Hepatitis, Chronic | NA | BeFree,CTD_human | Detail | |
| <0.001 | insulinoma | NA | BeFree | Detail | |
| <0.001 | leukemia | NA | BeFree | Detail | |
| <0.001 | Leukoplakia | NA | BeFree | Detail | |
| <0.001 | liver cirrhosis | NA | BeFree | Detail | |
| 0.002 | Biliary cirrhosis | NA | GAD | Detail | |
| <0.001 | Liver neoplasms | NA | BeFree | Detail | |
| 0.009 | Lung Neoplasms | NA | BeFree,LHGDN | Detail | |
| <0.001 | lymphoma | NA | BeFree | Detail | |
| 0.003 | Malignant neoplasm of stomach | NA | BeFree | Detail | |
| 0.120 | Neoplasm Invasiveness | NA | CTD_human | Detail | |
| 0.015 | Neoplasm Metastasis | We found a significant statistical correlation between levels of CK-18, CK-19 an... | BeFree,LHGDN | 24934364 | Detail |
| 0.015 | Neoplasm Metastasis | The study data demonstrated that an OSNA assay using CK19 mRNA was applicable fo... | BeFree,LHGDN | 25190122 | Detail |
| 0.015 | Neoplasm Metastasis | Of note, a portion of CK19-negative primary tumors showed upregulation of CK19 p... | BeFree,LHGDN | 25453845 | Detail |
| 0.015 | Neoplasm Metastasis | A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and me... | BeFree,LHGDN | 25476897 | Detail |
| <0.001 | neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Nodule | Hyperthyroidism induced by T3 treatment caused up-regulation of TRβ1 and of its ... | BeFree | 25156012 | Detail |
| <0.001 | oral submucous fibrosis | NA | BeFree | Detail | |
| 0.003 | Paget Disease Extramammary | NA | BeFree,LHGDN | Detail | |
| <0.001 | Pancreatic Diseases | NA | BeFree | Detail | |
| <0.001 | periodontitis | Expression of cytokeratin 19 (CK19) was markedly increased in the basement membr... | BeFree | 25037760 | Detail |
| <0.001 | Skin Neoplasms | NA | BeFree | Detail | |
| 0.005 | Stomach Neoplasms | NA | LHGDN | Detail | |
| <0.001 | synovial sarcoma | Forty monophasic spindle cell type (58.8%), 13 biphasic (19.1%), 12 poorly diffe... | BeFree | 25912315 | Detail |
| <0.001 | Thoracic Neoplasms | Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. | BeFree | 25453845 | Detail |
| 0.003 | thymoma | NA | LHGDN | Detail | |
| 0.006 | Thyroid Neoplasm | NA | BeFree,LHGDN | Detail | |
| <0.001 | Small cell carcinoma of lung | Most thoracic tumors, except for PCs, CTs, and SCCs, were positive for CK19. | BeFree | 25453845 | Detail |
| <0.001 | Thyroid Gland Follicular Adenoma | HBME-1 and CK 19 stained strong and diffuse positive in FV-TPCs but weak and foc... | BeFree | 24947099 | Detail |
| <0.001 | Atrophic condition of skin | NA | BeFree | Detail | |
| <0.001 | Adenocarcinoma of lung (disorder) | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree | 25453845 | Detail |
| <0.001 | Secondary malignant neoplasm of lung | NA | BeFree | Detail | |
| 0.001 | Tumor Progression | NA | BeFree | Detail | |
| <0.001 | follicular adenoma | HBME-1 and CK 19 stained strong and diffuse positive in FV-TPCs but weak and foc... | BeFree | 24947099 | Detail |
| <0.001 | hepatoblastoma | NA | BeFree | Detail | |
| <0.001 | Follicular thyroid carcinoma | NA | BeFree | Detail | |
| 0.005 | cholangiocarcinoma | NA | BeFree,LHGDN | Detail | |
| <0.001 | Carcinoma, Large Cell | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree | 25453845 | Detail |
| <0.001 | Neuroendocrine Tumors | NA | BeFree | Detail | |
| <0.001 | pancreatic carcinoma | NA | BeFree | Detail | |
| <0.001 | Medullary carcinoma of thyroid | NA | BeFree | Detail | |
| 0.001 | Papillary thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | islet cell tumor | NA | BeFree | Detail | |
| 0.004 | Malignant neoplasm of lung | Compared with the traditional lung cancer diagnostic biomarkers carcinoembryonic... | BeFree | 25961003 | Detail |
| <0.001 | Neoplasm, Residual | NA | BeFree | Detail | |
| <0.001 | Carcinoma, Small Cell | Most thoracic tumors, except for PCs, CTs, and SCCs, were positive for CK19. | BeFree | 25453845 | Detail |
| 0.004 | Carcinoma breast stage IV | NA | BeFree | Detail | |
| <0.001 | Cancer of Head and Neck | Effects of EGFR, CK19, CK20 and Survinin gene expression on radiotherapy results... | BeFree | 25854400 | Detail |
| 0.120 | Squamous cell carcinoma of esophagus | NA | BeFree,CTD_human | Detail | |
| <0.001 | Conventional (Clear Cell) Renal Cell Carcinoma | NA | BeFree | Detail | |
| <0.001 | Solid tumour | NA | BeFree | Detail | |
| <0.001 | stage, cervical cancer | NA | BeFree | Detail | |
| <0.001 | Prostatic Intraepithelial Neoplasias | NA | BeFree | Detail | |
| 0.001 | cervix carcinoma | NA | BeFree | Detail | |
| 0.003 | Focal Nodular Hyperplasia | NA | LHGDN | Detail | |
| <0.001 | pleomorphic carcinoma | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree | 25453845 | Detail |
| <0.001 | Carcinoid tumor no ICD-O subtype | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree | 25453845 | Detail |
| <0.001 | Polymorphous corneal dystrophy | NA | BeFree | Detail | |
| <0.001 | multinodular goiter | NA | BeFree | Detail | |
| <0.001 | malignant mesothelioma | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree | 25453845 | Detail |
| <0.001 | Juvenile fibroadenoma of breast | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of pancreas | NA | BeFree | Detail | |
| <0.001 | Secondary malignant neoplasm of bone marrow | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of prostate | NA | BeFree | Detail | |
| <0.001 | Hematologic Neoplasms | NA | BeFree | Detail | |
| <0.001 | Occult carcinoma | NA | BeFree | Detail | |
| <0.001 | endometrial carcinoma | The study data demonstrated that an OSNA assay using CK19 mRNA was applicable fo... | BeFree | 25190122 | Detail |
| <0.001 | Increased drug resistance | NA | BeFree | Detail | |
| <0.001 | Thyroid carcinoma | NA | BeFree | Detail | |
| <0.001 | hyperhomocysteinemia | NA | BeFree | Detail | |
| <0.001 | prostate carcinoma | NA | BeFree | Detail | |
| <0.001 | Hashimoto Disease | NA | BeFree | Detail | |
| 0.004 | Sentinel node (disorder) | The purpose of this study was to compare the performance of one-step nucleic aci... | BeFree | 24912612 | Detail |
| 0.004 | Sentinel node (disorder) | For performance evaluations using SLNs (120 histopathologically negative LNs and... | BeFree | 25190122 | Detail |
| 0.022 | breast carcinoma | Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the... | BeFree | 24958324 | Detail |
| 0.022 | breast carcinoma | Keratin 19 expression correlates with poor prognosis in breast cancer. | BeFree | 25156534 | Detail |
| 0.022 | breast carcinoma | Expression of CK19 was also detected in 90.9% of lung metastatic deposits from b... | BeFree | 25453845 | Detail |
| 0.003 | Carcinoma of lung | Compared with the traditional lung cancer diagnostic biomarkers carcinoembryonic... | BeFree | 25961003 | Detail |
| 0.004 | Secondary malignant neoplasm of lymph node | Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. | BeFree | 25453845 | Detail |
| <0.001 | colon carcinoma | The purpose of this study was to compare the performance of one-step nucleic aci... | BeFree | 24912612 | Detail |
| 0.003 | stomach carcinoma | NA | BeFree | Detail | |
| <0.001 | Central neuroblastoma | NA | BeFree | Detail | |
| <0.001 | Dissecting aneurysm of the thoracic aorta | NA | BeFree | Detail | |
| <0.001 | biliary tract cancer | NA | BeFree | Detail | |
| <0.001 | malignant pleural mesothelioma | We examined CK19 expression in specimens from a total of 801 surgically resected... | BeFree | 25453845 | Detail |
| <0.001 | Colorectal cancer metastatic | NA | BeFree | Detail | |
| <0.001 | Hurthle Cell Tumor | NA | BeFree | Detail | |
| <0.001 | Pancreatic carcinoma stage I | NA | BeFree | Detail | |
| <0.001 | Squamous cell carcinoma of the head and neck | NA | BeFree | Detail | |
| <0.001 | large cell neuroendocrine carcinoma | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree | 25453845 | Detail |
| <0.001 | Collecting Duct Carcinoma of the Kidney | NA | BeFree | Detail | |
| <0.001 | hepatoid adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Atypical Ductal Breast Hyperplasia | NA | BeFree | Detail | |
| <0.001 | pancreatic ductal adenocarcinoma | NA | BeFree | Detail | |
| <0.001 | Thyroid Gland Oncocytic Adenoma | NA | BeFree | Detail | |
| <0.001 | Epithelioma | NA | BeFree | Detail | |
| 0.012 | Mammary Neoplasms | The detection limit of duplex real-time RT-PCR assay using KRT19 and ERBB2 as ta... | BeFree,LHGDN | 25353649 | Detail |
| <0.001 | Xenograft Model | NA | BeFree | Detail | |
| 0.002 | colorectal cancer | NA | BeFree | Detail | |
| <0.001 | Cirrhosis | NA | BeFree | Detail | |
| <0.001 | Laryngeal cleft | NA | BeFree | Detail | |
| <0.001 | MULTICYSTIC RENAL DYSPLASIA, BILATERAL | NA | BeFree | Detail | |
| 0.120 | Copper-Overload Cirrhosis | NA | CTD_human | Detail | |
| <0.001 | uterine corpus cancer | The study data demonstrated that an OSNA assay using CK19 mRNA was applicable fo... | BeFree | 25190122 | Detail |
| <0.001 | Urothelial Carcinoma | NA | BeFree | Detail | |
| 0.013 | liver carcinoma | A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and me... | BeFree,LHGDN | 25476897 | Detail |
| 0.001 | Nasopharyngeal carcinoma | NA | BeFree | Detail | |
| 0.002 | Early-Stage Breast Carcinoma | NA | BeFree | Detail | |
| <0.001 | Homocysteinemia | NA | BeFree | Detail | |
| 0.003 | adenocarcinoma | NA | BeFree,LHGDN | Detail | |
| 0.003 | adenoma | NA | LHGDN | Detail | |
| 0.120 | asthma | NA | BeFree,CTD_human | Detail | |
| 0.022 | Malignant neoplasm of breast | Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the... | BeFree | 24958324 | Detail |
| 0.022 | Malignant neoplasm of breast | Keratin 19 expression correlates with poor prognosis in breast cancer. | BeFree | 25156534 | Detail |
| 0.022 | Malignant neoplasm of breast | Expression of CK19 was also detected in 90.9% of lung metastatic deposits from b... | BeFree | 25453845 | Detail |
| 0.003 | Carcinoid Tumor | CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.... | BeFree,LHGDN | 25453845 | Detail |
| <0.001 | Malignant tumor of colon | The purpose of this study was to compare the performance of one-step nucleic aci... | BeFree | 24912612 | Detail |
| <0.001 | Malignant neoplasm of endometrium | The study data demonstrated that an OSNA assay using CK19 mRNA was applicable fo... | BeFree | 25190122 | Detail |
| <0.001 | Malignant neoplasm of skin | NA | BeFree | Detail | |
| <0.001 | Malignant neoplasm of thyroid | NA | BeFree | Detail | |
| 0.003 | basal cell carcinoma | NA | LHGDN | Detail | |
| <0.001 | Noninfiltrating Intraductal Carcinoma | NA | BeFree | Detail | |
| 0.002 | Non-small cell lung carcinoma | The expression of CK-19, EGFR and MUC-1 was evaluated by RT-PCR in the NSCLC tum... | BeFree | 26214631 | Detail |
| 0.009 | Carcinoma, Papillary | NA | BeFree,LHGDN | Detail | |
| <0.001 | renal cell carcinoma | NA | BeFree | Detail |
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We found a significant statistical correlation between levels of CK-18, CK-19 and CEA mRNA. mRNA exp... | DisGeNET | Detail |
| The study data demonstrated that an OSNA assay using CK19 mRNA was applicable for detecting LN metas... | DisGeNET | Detail |
| Of note, a portion of CK19-negative primary tumors showed upregulation of CK19 protein expression in... | DisGeNET | Detail |
| A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatoce... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Hyperthyroidism induced by T3 treatment caused up-regulation of TRβ1 and of its target genes in Krt-... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Expression of cytokeratin 19 (CK19) was markedly increased in the basement membranes of the oral epi... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Forty monophasic spindle cell type (58.8%), 13 biphasic (19.1%), 12 poorly differentiated (17.6%) an... | DisGeNET | Detail |
| Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Most thoracic tumors, except for PCs, CTs, and SCCs, were positive for CK19. | DisGeNET | Detail |
| HBME-1 and CK 19 stained strong and diffuse positive in FV-TPCs but weak and focal in FAs. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| HBME-1 and CK 19 stained strong and diffuse positive in FV-TPCs but weak and focal in FAs. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Compared with the traditional lung cancer diagnostic biomarkers carcinoembryonic antigen and cytoker... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Most thoracic tumors, except for PCs, CTs, and SCCs, were positive for CK19. | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Effects of EGFR, CK19, CK20 and Survinin gene expression on radiotherapy results in patients with lo... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The study data demonstrated that an OSNA assay using CK19 mRNA was applicable for detecting LN metas... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The purpose of this study was to compare the performance of one-step nucleic acid amplification (OSN... | DisGeNET | Detail |
| For performance evaluations using SLNs (120 histopathologically negative LNs and 17 histopathologica... | DisGeNET | Detail |
| Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of th... | DisGeNET | Detail |
| Keratin 19 expression correlates with poor prognosis in breast cancer. | DisGeNET | Detail |
| Expression of CK19 was also detected in 90.9% of lung metastatic deposits from breast carcinomas. | DisGeNET | Detail |
| Compared with the traditional lung cancer diagnostic biomarkers carcinoembryonic antigen and cytoker... | DisGeNET | Detail |
| Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases. | DisGeNET | Detail |
| The purpose of this study was to compare the performance of one-step nucleic acid amplification (OSN... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| We examined CK19 expression in specimens from a total of 801 surgically resected samples of primary ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The detection limit of duplex real-time RT-PCR assay using KRT19 and ERBB2 as targeted genes was con... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The study data demonstrated that an OSNA assay using CK19 mRNA was applicable for detecting LN metas... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatoce... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| Detection of circulating cytokeratin-19 mRNA-positive cells in the blood and the mitotic index of th... | DisGeNET | Detail |
| Keratin 19 expression correlates with poor prognosis in breast cancer. | DisGeNET | Detail |
| Expression of CK19 was also detected in 90.9% of lung metastatic deposits from breast carcinomas. | DisGeNET | Detail |
| CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of ... | DisGeNET | Detail |
| The purpose of this study was to compare the performance of one-step nucleic acid amplification (OSN... | DisGeNET | Detail |
| The study data demonstrated that an OSNA assay using CK19 mRNA was applicable for detecting LN metas... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| The expression of CK-19, EGFR and MUC-1 was evaluated by RT-PCR in the NSCLC tumor and paired adjace... | DisGeNET | Detail |
| NA | DisGeNET | Detail |
| NA | DisGeNET | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr17:39,679,869-39,684,560
- Variant Type
- snv
Genome browser